CD44<sup>+</sup>/CD24<sup>-</sup> phenotype predicts a poor prognosis in triple-negative breast cancer.

Oncol Lett · 2017 · PMC5661458 · PMID 29113223

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, according to the present data from Kaplan-Meier curves of estimated DFS and OS, the CD44 − /CD24 + phenotype in TNBC may also be associated with a trend for an increased risk of recurrence or mortality when compared with the CD44 − /CD24 − phenotype, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.